143 related articles for article (PubMed ID: 10365725)
1. Filgrastim for treatment of neutropenia in a neonate.
Berndt EM; Stavris MA; Hanna M; Allen P; Kulick J
Am J Health Syst Pharm; 1999 May; 56(10):995-7. PubMed ID: 10365725
[No Abstract] [Full Text] [Related]
2. Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy.
Sangalli MR; Peek M; McDonald A
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):470-1. PubMed ID: 11787932
[No Abstract] [Full Text] [Related]
3. Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim).
Sotomatsu M; Kanazawa T; Ogawa C; Watanabe T; Morikawa A
Br J Haematol; 2000 Jul; 110(1):234-5. PubMed ID: 10931006
[No Abstract] [Full Text] [Related]
4. Congenital autoimmune neutropenia in two premature neonates.
Calhoun DA; Rimsza LM; Burchfield DJ; Millsaps M; Christensen RD; Budania J; McCullough J
Pediatrics; 2001 Jul; 108(1):181-4. PubMed ID: 11433074
[TBL] [Abstract][Full Text] [Related]
5. Novel treatment for severe congenital neutropenia with pegfilgrastim.
Choi LM; Guelcher C; Guerrera MF
Blood; 2007 Dec; 110(12):4134. PubMed ID: 18024801
[No Abstract] [Full Text] [Related]
6. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
Cottle TE; Fier CJ; Donadieu J; Kinsey SE
Semin Hematol; 2002 Apr; 39(2):134-40. PubMed ID: 11957197
[TBL] [Abstract][Full Text] [Related]
7. Multiple, repeated filgrastim treatment cycles to recover severe, recurring pegylated interferon-related neutropenia.
Manfredi R; Sabbatani S
Hepatogastroenterology; 2007 Sep; 54(78):4 page preceeding table content. PubMed ID: 18019674
[No Abstract] [Full Text] [Related]
8. XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy.
Engert A; Griskevicius L; Zyuzgin Y; Lubenau H; del Giglio A
Leuk Lymphoma; 2009 Mar; 50(3):374-9. PubMed ID: 19347726
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony stimulating factor in neonatal alloimmune neutropenia: a possible association with induced thrombocytopenia.
Wiedl C; Walter AW
Pediatr Blood Cancer; 2010 Jul; 54(7):1014-6. PubMed ID: 20135695
[TBL] [Abstract][Full Text] [Related]
10. Low-dose filgrastim therapy for chronic neutropenia.
Kaczmarski RS; Mufti GJ
N Engl J Med; 1993 Oct; 329(17):1280-1. PubMed ID: 7692296
[No Abstract] [Full Text] [Related]
11. G-CSF: filgrastim, lenograstim and biosimilars.
Welte K
Expert Opin Biol Ther; 2014 Jul; 14(7):983-93. PubMed ID: 24707817
[TBL] [Abstract][Full Text] [Related]
12. [Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia].
Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; Durán Pérez-Navarro A
An Med Interna; 1995 Feb; 12(2):100-1. PubMed ID: 7538330
[No Abstract] [Full Text] [Related]
13. How I manage children with neutropenia.
Dale DC
Br J Haematol; 2017 Aug; 178(3):351-363. PubMed ID: 28419427
[TBL] [Abstract][Full Text] [Related]
14. Filgrastim (r-metHuG-CSF) in the 21st century: SD/01.
Morstyn G; Foote MA; Walker T; Molineux G
Acta Haematol; 2001; 105(3):151-5. PubMed ID: 11463988
[TBL] [Abstract][Full Text] [Related]
15. Using filgrastim efficiently.
Dranitsaris G
Pharmacoeconomics; 1996 May; 9(5):466-8. PubMed ID: 10161379
[No Abstract] [Full Text] [Related]
16. Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropenia.
Crawford J
Drugs; 2002; 62 Suppl 1():89-98. PubMed ID: 12479597
[TBL] [Abstract][Full Text] [Related]
17. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.
Frampton JE; Lee CR; Faulds D
Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630
[TBL] [Abstract][Full Text] [Related]
18. Haematopoietic growth factors in children with neutropenia.
Lehrnbecher T; Welte K
Br J Haematol; 2002 Jan; 116(1):28-56. PubMed ID: 11841397
[No Abstract] [Full Text] [Related]
19. Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.
Schwab G; Hecht T
Ann Hematol; 1994 Jul; 69(1):1-9. PubMed ID: 7520285
[No Abstract] [Full Text] [Related]
20. XM02, the first biosimilar G-CSF, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with small cell or non-small cell lung cancer receiving platinum-based chemotherapy.
Gatzemeier U; Ciuleanu T; Dediu M; Ganea-Motan E; Lubenau H; Del Giglio A
J Thorac Oncol; 2009 Jun; 4(6):736-40. PubMed ID: 19404210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
